China Resources Shuanghe announced that its wholly-owned subsidiary China Resources Shuanghe Limin Pharmaceutical (Jinan) Co., Ltd. received the “Drug Registration Certificate” for resorcinol injections issued by the State Drug Administration. This drug is used to treat acute cramps and pain caused by digestive system and biliary tract dysfunction.
华润双鹤：全资子公司间苯三酚注射液获药品注册证书
China Resources Shuanghe: A wholly-owned subsidiary obtained a drug registration certificate for its resorcinol injection
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.